Liver cancer
Open
Phase 2
This trial is looking at giving pembrolizumab and lenvatinib before surgery for people with liver cancer.
It is open to people with a type of liver cancer called hepatocellular carcinoma.
Recruitment start: 28 August 2022
Recruitment end: 31 July 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Meyer
University College London (UCL)
Merck, Sharp & Dohme
Cancer Research UK & UCL Cancer Trials Centre
Last reviewed: 29 Jan 2026
CRUK internal database number: 18562
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
